Bone Biologics Corporation

NASDAQ (USD): Bone Biologics Corporation (BBLG)

Last Price

2.08

Today's Change

+0.35 (20.23%)

Day's Change

1.73 - 2.34

Trading Volume

9,333,764

Overview

Market Cap

3 Million

Shares Outstanding

1 Million

Avg Volume

4,828,664

Avg Price (50 Days)

1.51

Avg Price (200 Days)

2.30

PE Ratio

-0.12

EPS

-17.24

Earnings Announcement

12-Nov-2024

Previous Close

1.73

Open

1.75

Day's Range

1.7348 - 2.34

Year Range

0.8 - 10.56

Trading Volume

9,340,060

Price Change Highlight

1 Day Change

20.23%

5 Day Change

66.40%

1 Month Change

38.67%

3 Month Change

39.60%

6 Month Change

-6.31%

Ytd Change

-49.76%

1 Year Change

-64.86%

3 Year Change

-99.83%

5 Year Change

-99.93%

10 Year Change

-99.99%

Max Change

-99.99%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment